Eun Seo Jang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eun Seo Jang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Eun La Kim
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea
3 shared publications - Hyeon-Jeong Hwang
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea
3 shared publications - Seoung Rak Lee
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea
3 shared publications - Yeo Jin Lee
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea
3 shared publications - Youngsang Nam
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea
3 shared publications - Chaeyun Hong
College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 5 November 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1169
Host-Associated Metabolites of the Marine Roseobacter-Group: Chemical Diversity, Biosynthesis, Ecological Functions and Bioactivities
Marine microorganisms, particularly members of the marine Roseobacter-group, participate in chemically mediated associations with phytoplankton, macroalgae, and marine invertebrates. This review examines structurally characterized, host-associated metabolites produced by Roseobacter-group bacteria within this ecological framework. These metabolites include sulfur-containing compounds, nitrogen-containing and hybrid scaffolds, pigments, lipids, and signaling molecules, exemplified by the antibacterial tropodithietic acid and the algaecidal roseobacticides. We discuss biosynthetic connections between phenylacetate and sulfur metabolism that give rise to tropodithietic acid and roseobacticides, as well as tryptophan–sinapic-acid-derived hybrid pathways. By integrating genomic potential, host-derived elicitors, metabolomics, structure elucidation, and experimentally demonstrated activities, this review distinguishes chemically characterized products from bioinformatically predicted pathways and proposed applications.
- 5 November 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1169
Open AccessHost-Associated Metabolites of the Marine Roseobacter-Group: Chemical Diversity, Biosynthesis, Ecological Functions and Bioactivities
Marine microorganisms, particularly members of the marine Roseobacter-group, participate in chemically mediated associations with phytoplankton, macroalgae, and marine invertebrates. This review examines structurally characterized, host-associated metabolites produced by Roseobacter-group bacteria within this ecological framework. These metabolites include sulfur-containing compounds, nitrogen-containing and hybrid scaffolds, pigments, lipids, and signaling molecules, exemplified by the antibacterial tropodithietic acid and the algaecidal roseobacticides. We discuss biosynthetic connections between phenylacetate and sulfur metabolism that give rise to tropodithietic acid and roseobacticides, as well as tryptophan–sinapic-acid-derived hybrid pathways. By integrating genomic potential, host-derived elicitors, metabolomics, structure elucidation, and experimentally demonstrated activities, this review distinguishes chemically characterized products from bioinformatically predicted pathways and proposed applications.
- Open Access
- 30 June 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (7) , 275
Isolation and Characterization of Secondary Metabolites from Hydractinia-Associated Fungus, Penicillium brevicompactum MSW10-1, and Their Inhibitory Effects on Hepatic Lipogenesis
Marine organism-associated microbes are an important source of structurally diverse and biologically active secondary metabolites exhibiting antimicrobial, anticancer, and anti-inflammatory activities. In this study, we investigated Penicillium brevicompactum MSW10-1, isolated from Hydractinia echinata, a marine invertebrate adapted to extreme intertidal and subtidal environments with variable temperature, salinity, and oxygen conditions. Through a combination of LC/MS-guided chemical analysis and chromatographic purification, eight secondary metabolites were isolated, including brevicolactones A (1) and B (2). The absolute chemical structures of 1 and 2 were determined based on NMR spectroscopic experiments, HR-ESIMS data, and quantum chemical ECD calculations. The isolated compounds (1–8) were evaluated for their ability to inhibit hepatic lipogenesis, a key process in lipid metabolism that is dysregulated in metabolic-dysfunction-associated steatotic liver disease. Furthermore, the inhibitory effects of the isolated compounds on lipid accumulation were further evaluated in primary mouse hepatocytes, using Oil Red O staining. These findings suggested that the isolated compounds may serve as promising candidates for the treatment of metabolic liver diseases associated with lipid dysregulation.
- 30 June 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (7) , 275
Open AccessIsolation and Characterization of Secondary Metabolites from Hydractinia-Associated Fungus, Penicillium brevicompactum MSW10-1, and Their Inhibitory Effects on Hepatic Lipogenesis
Marine organism-associated microbes are an important source of structurally diverse and biologically active secondary metabolites exhibiting antimicrobial, anticancer, and anti-inflammatory activities. In this study, we investigated Penicillium brevicompactum MSW10-1, isolated from Hydractinia echinata, a marine invertebrate adapted to extreme intertidal and subtidal environments with variable temperature, salinity, and oxygen conditions. Through a combination of LC/MS-guided chemical analysis and chromatographic purification, eight secondary metabolites were isolated, including brevicolactones A (1) and B (2). The absolute chemical structures of 1 and 2 were determined based on NMR spectroscopic experiments, HR-ESIMS data, and quantum chemical ECD calculations. The isolated compounds (1–8) were evaluated for their ability to inhibit hepatic lipogenesis, a key process in lipid metabolism that is dysregulated in metabolic-dysfunction-associated steatotic liver disease. Furthermore, the inhibitory effects of the isolated compounds on lipid accumulation were further evaluated in primary mouse hepatocytes, using Oil Red O staining. These findings suggested that the isolated compounds may serve as promising candidates for the treatment of metabolic liver diseases associated with lipid dysregulation.
- Open Access
- 26 December 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (1) , 6
Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions
Cancer remains a significant medical challenge, necessitating the discovery of novel therapeutic agents. Ribosomally synthesized and post-translationally modified peptides (RiPPs) from plants have emerged as a promising source of anticancer compounds, offering unique structural diversity and potent biological activity. This review identifies and discusses cytotoxic RiPPs across various plant families, focusing on their absolute chemical structures and reported cytotoxic activities against cancer cell lines. Notably, plant-derived RiPPs such as rubipodanin A and mallotumides A–C demonstrated low nanomolar IC50 values against multiple cancer cell types, highlighting their therapeutic potential. By integrating traditional ethnobotanical knowledge with modern genomic and bioinformatic approaches, this study underscores the importance of plant RiPPs as a resource for developing innovative cancer treatments. These findings pave the way for further exploration of plant RiPPs, emphasizing their role in addressing the ongoing challenges in oncology and enhancing the repertoire of effective anticancer therapies.
- 26 December 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (1) , 6
Open AccessAnticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions
Cancer remains a significant medical challenge, necessitating the discovery of novel therapeutic agents. Ribosomally synthesized and post-translationally modified peptides (RiPPs) from plants have emerged as a promising source of anticancer compounds, offering unique structural diversity and potent biological activity. This review identifies and discusses cytotoxic RiPPs across various plant families, focusing on their absolute chemical structures and reported cytotoxic activities against cancer cell lines. Notably, plant-derived RiPPs such as rubipodanin A and mallotumides A–C demonstrated low nanomolar IC50 values against multiple cancer cell types, highlighting their therapeutic potential. By integrating traditional ethnobotanical knowledge with modern genomic and bioinformatic approaches, this study underscores the importance of plant RiPPs as a resource for developing innovative cancer treatments. These findings pave the way for further exploration of plant RiPPs, emphasizing their role in addressing the ongoing challenges in oncology and enhancing the repertoire of effective anticancer therapies.